PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathway-Reference-Cited by-同舟云学术

PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathway

Published:2019-10 Issue: Volume:47 Page:101440
ISSN:0890-8508
Container-title:Molecular and Cellular Probes
language:en
Short-container-title:Molecular and Cellular Probes

Author:

Park Song,Han Se-Hyeon,Kim Hyeon-Gyeom,Jeong Jain,Choi Minjee,Kim Hee-Yeon,Kim Min-Gi,Park Jin-Kyu,Han Jee Eun,Cho Gil-Jae,Kim Myoung Ok,Ryoo Zae Young,Choi Seong-Kyoon

Funder

National Research Foundation of Korea (NRF)

Ministry of Education

Korean Government Ministry of Trade, Industry, and Energy

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference35 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

2. Molecular portraits of human breast tumours;Perou;Nature,2000

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc. Natl. Acad. Sci. U.S.A.,2001